Second campaign to promote the colon cancer screening programme through swiss community pharmacies

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-CPS-134
• By: BESANCON, Luc (pharmaSuisse, Innovation and International)
• Co-author(s): Daniela Stebler: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
  Andrea Brügger: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
  Martine Ruggli: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
  Luc Besançon: Innovation and International, pharmaSuisse, Bern-Liebefeld, Switzerland
  Fabian Vaucher: pharmaSuisse, Bern-Liebefeld, Switzerland
  
• Abstract:

  Background

  In Switzerland, 4300 new patients are diagnosed every year with colon cancer, leading to 1700 deaths. Early detection is therefore key.

  Methods

  pharmaSuisse has developed a service integrating stool test for early detection of colon cancer. Patients are first screened. If no red flags are detected, they receive the stool test as well as

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login